Beigene Ltd Ads (NQ: BGNE )

334.90 USD +2.43 (+0.73%)

Official Closing Price Updated: 7:06 PM EST, Feb 24, 2021 Add to My Watchlist

Price and Volume

Volume	215,400
Open	326.68
Bid (Size)	300.05 (1)
Ask (Size)	334.55 (1)
Prev. Close	332.47
Today's Range	322.25 - 339.89
52wk Range	118.55 - 388.97
Shares Outstanding	53,760,296
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Boston Immune Technologies and Therapeutics and BeiGene Enter into an Exclusive Option and License Agreement to Develop Novel TNFR2 Antagonists

February 17, 2021

Boston Immune Technologies and Therapeutics and BeiGene Enter into an Exclusive Option and License Agreement to Develop Novel TNFR2 Antagonists

BeiGene Announces U.S. FDA Acceptance of Supplemental New Drug Application for BRUKINSA (Zanubrutinib) in Waldenström’s Macroglobulinemia

February 17, 2021

BeiGene Announces U.S. FDA Acceptance of Supplemental New Drug Application for BRUKINSA (Zanubrutinib) in Waldenström’s Macroglobulinemia

Performance

YTD	+28.31%	+28.31%
1 Month	-11.15%	-11.15%
3 Month	+26.78%	+26.78%
6 Month	+34.36%	+34.36%
1 Year	+111.19%	+111.19%

More News

BeiGene Announces Positive Topline Results for Global Phase 3 Trial of Tislelizumab in Esophageal Squamous Cell Carcinoma

January 27, 2021

BeiGene's US Application For BRUKINSA In A Type Of Lymphoma, Accepted For Review

February 17, 2021

Stocks Showing Improving Market Leadership: Beigene Earns 84 RS Rating

Today 3:00 EST

Week In Review: Yuanxin Raises $465 Million For Online Healthcare Company Miaoshou Doctor

February 20, 2021

EUSA Pharma and BeiGene Announce Acceptance of a Biologics License Application for SYLVANT® (Siltuximab for Injection) in China

January 25, 2021

bye bye BGNE and Mexichem

February 09, 2021

Stock Squeeze Remnants

February 01, 2021

Week In Review: Matridx Raises $32 Million For AI/CRISPR-Cas Pathogen Metagenomics Diagnostic Devices

January 30, 2021

The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal

February 17, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.